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Abstract
Background: In Finland, a national programme for COPD prevention and treatment was developed in 1998. The
main goals of the programme were to diagnose COPD as early as possible and to encourage people to quit
smoking. The role of primary health care was emphasized in the programme. Our aim was to investigate the use
of spirometry and recording of smoking habits of COPD patients in primary health care before and during the
COPD programme.
Methods: We compared patients with respiratory symptoms or diseases visiting primary health care during 1997
(before programme) and 2002 (during programme). Patients with respiratory symptoms were divided into two
groups: COPD patients and “others”. Patient records were thoroughly investigated and data retrieved from them.
Results: There was a significant increase in the whole study group from 8.0% to 38.9% in the use of spirometry
(p < 0.001). This increase was significant both in the COPD group (from 32.0% to 79.6%, p < 0.001) and “others”
(from 5.6% to 32.8%, p < 0.001). Written information on smoking habits in patient records increased from 16.6% of
all patients in 1997 to 53.2% in 2002 (p < 0.001), and in COPD group from 45.0% to 84.3% (p < 0.001).
Conclusions: We observed a significant increase in the use of spirometry and knowledge of smoking habits in
COPD patients, which may be a result of the Finnish national COPD programme.
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Background
Chronic obstructive pulmonary disease (COPD) is a major
health problem causing morbidity and mortality world-
wide [1-3]. The incidence of COPD is increasing and its
financial impact escalating [4]. International and national
guidelines of COPD have been published recently to stan-
dardize in order to make the diagnosis and treatment of
the disease equal in different settings [5-7].
COPD should be diagnosed using the appropriate mea-
surements of lung function [8-11]. In the early stage of
COPD airflow obstruction can be present without caus-
ing symptoms. Especially this group warrants an early
diagnosis, and the role of primary healthcare physicians
is crucial in this respect [9,12]. There are some reports
that indicate shortcomings of the detection of COPD in
primary care such as underuse of spirometry, in its diag-
nosis [13-16]. Cigarette smoking is the major risk factor
for the disease, and the importance of smoking cessation
has been shown in preventing further decline of lung
function [17]. Knowledge of patients smoking habits is
essential both in diagnosis and treatment of COPD [18].
In Finland, the National Programme for Chronic
Bronchitis and Chronic Obstructive Pulmonary Disease
1998-2007 was designed by The Finnish Lung Health
Association (Filha, NGO) in cooperation with the Minis-
try of Social Affairs and Health and the Pulmonary
Association Heli (NGO) with the help of a working
g r o u po fe x p e r t s .I tw a ss u b s e q u e n t l yp u b l i s h e do n
behalf of the Ministry of Social Affairs and Health in
1998 for 10 years [19]. The main goals of the pro-
gramme were to diagnose COPD as early as possible
and to encourage people to quit smoking. The role of
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COPD was emphasized in the programme. A nation-
wide implementation was performed in specialized as
well as in primary health care, coordinated by Filha. At
first, they were collaborating together with all [21] hos-
pital districts (especially their pulmonary clinics) and all
[6] occupational health districts to organize training
events together with hospitals, and primary health care
personnel were also invited. The topics were COPD as a
disease, diagnosis of COPD (spirometry), smoking cessa-
tion and treatment of COPD. Secondly the training
events were organized in collaboration with 156 (of 270)
primary health care centers that were interested and
willing to participate in this training. These sessions
were arranged at health care stations during the working
day (2-4 hours per time). All training was multidisciplin-
ary. Approximately one third of the participants were
doctors and two thirds nurses. From 1997 to 2002,
approximately 210 training events for recognition of
COPD were arranged around the country. As many as 8
200 health care professionals attended the meetings.
Two information and training opportunities were
offered to the personnel of each health care center dur-
ing 5 years. The evidence-based Finnish Current Care
Guidelines for COPD were introduced in 1999, and
were also included in the implementation [20]. As far as
we know there are no data concerning the effects of
national programmes on diagnosis of COPD in primary
health care.
T h ep r e s e n ts t u d ya i m e dt oi n v e s t i g a t et h eu s eo f
spirometry in diagnosis and follow-up of COPD patients
and recording of smoking habits in a primary health
care center before and during the national COPD
programme.
Methods
A medium-sized primary healthcare center in south-west
Finland with computerized patient records was chosen
for the study. The healthcare center chosen used electro-
nic patient record system for all patient data archiving.
For every patient visit an International Classification of
Primary Care (ICPC) code was recorded, and information
concerning the cause of visit, clinical findings, results of
examinations and treatment suggested was documented.
Subjects were all aged > 16 years to include all adults vis-
iting primary health care due to respiratory symptoms.
The year 1997 was chosen to represent the situation in
the country before the introduction of the 1998 national
programme and campaign for detecting and treating
COPD, and the year 2002 to represent the impact of the
programme.
The population living in the area of this healthcare cen-
t e ri n1 9 9 7w a s4 44 0 2 ,o fw h o m3 61 7 0w e r ea g e d>1 6
years. The figures for 2002 were 46 063 and 37 444,
respectively. In 1997 and 2002, the number of doctor
visits for all causes was 85,535 and 89,787, respectively.
For every visit a main diagnosis routinely documented by
the treating physician to the healthcare center records
was available for the study. All the visits due to respira-
tory symptoms or diseases were included in the study.
Visits due to COPD were identified retrospectively with
the help of ICPC (International classification of primary
care) [21] and International Statistical Classification of
Diseases and Related Health Problem (ICD10) codes
recorded. ICPC codes were used almost solely, and
ICD10 codes were used only during primary health care
in-hospital periods. In-hospital and polyclinical treatment
in specialized health care were not included in the study.
The doctors responsible for diagnosing and treating
patients did not know about the study when they met
the patients. Our aim was to discover all new and pre-
diagnosed COPD patients visiting primary health care
during each study year. We also included codes of other
obstructive respiratory diseases and symptoms suggestive
of COPD to find those COPD cases remaining undiag-
nosed. The overall diagnostic efforts done due to sugges-
tive respiratory symptoms by general practitioners were
studied. The diagnosis codes included were those of
chronic bronchitis, emphysema, COPD, asthma, cough,
dyspnea, wheezing, abnormal sputum and bronchiectasis.
Based on medical record data, patients with respira-
tory symptoms were divided into two groups: COPD
patients and “others”. The COPD group was of primary
interest. All the available data, including those before
our study period, were used.
To be included in the COPD group a patient had to
have:
- An earlier diagnosis of COPD made in specialized
health care (respiratory clinic).’ or
- A suitable history and deteriorated spirometric
values. FEV1 had to be ≤ 80% of the predicted value
and the FEV1/FVC ratio ≤ 80% according to Finnish
clinical practice and guidelines [19,22].
and
- Asthma excluded with peak expiratory (PEF) flow
measurement data (those having repeatedly ≥ 20% of
diurnal variation were excluded from the COPD
group).
Other cases formed the group of “others” with respira-
tory symptoms. Some had asthma or other respiratory
diseases, but most had only a variety of respiratory symp-
toms without specific diagnosis, or at least no diagnosis
was made according to the data available.
Pack-years of smoking were computed for current and
ex-smokers. One pack-year was regarded as equivalent
to 20 cigarettes smoked daily for 1 year. The variables
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spirometric values.
The main outcomes of the study were the frequency
of the use of spirometry for the diagnosis of respiratory
symptoms suggestive of COPD and the adequate record-
ing of smoking habits of those seeking medical advice
due to their respiratory symptoms.
The statistical analysis was carried out using SPSS and
SAS software. Categorical variables were tested by chi-
squared test, numerical variables by analysis of variance.
The study was approved by the Salo Healthcare Cen-
ter Ethical Committee and was performed in accordance
with the principles of the Declaration of Helsinki.
Results
In 1997 and 2002 a total of 1 072 and 1 645 patients
with respiratory symptoms were included, respectively.
The share of men was 38.3% (411) in 1997 and 37.0%
(609) in 2002 (Table 1).
The diagnosis of COPD had been made in 100 cases in
1997 and in 216 cases in 2002, or medical record data
made it possible to confirm COPD and exclude asthma
by the study team. These cases were included in the
COPD group. The remaining 972 patients in 1997 and 1
429 in 2002 formed the group “others”.I n1 9 9 73 3 2
(34.2%) of others had asthma, 7 (0.7%) had chronic bron-
chitis and the reminder, 633 (65.1%), of that group were
without any specific diagnosis. The figures for 2002 were
443 (31.0%), 26 (1.8%) and 960 (67.2%) respectively. The
demographic details of the groups are shown in Table 1.
Altogether 29.6 patients per 1 000 persons visited pri-
mary healthcare for respiratory symptoms in 1997, the
respective figure was 43.9 per 1 000 in 2002. The number
of patients visiting primary health care due to COPD was
2.4 per 1 000 persons in 1997 and 5.8 per 1 000 in 2002.
There was a significant increase in the whole study
group from 8.0% to 38.9% (p < 0.001) in the use of spiro-
metry in primary health care. This increase was significant
(p < 0.001) both in the COPD group (from 32.0% to
79.6%) and “others” (from 5.6% to 32.8%) (Table 1).
Written information on smoking habits in patient
records increased significantly from 16.6% of all patients
in 1997 to 53.2% in 2002 (p < 0.001). Such information
was obtained for 45.0% of patients in the COPD group in
1997, and significantly more often in 84.3% in 2002 (p <
0.001) (Table 1).
Discussion
According to our study, there was a clear increase in the
u s eo fs p i r o m e t r yi nC O P Dp a t i e n t sa sw e l la si na l l
patients with respiratory symptoms during the 5-year
period after the introduction of the COPD programme in
1997, but also Finnish asthma programme 1994-2004
[23] and evidence-based current care guidelines for
COPD in 1999 [20] may partly explain this. Written
information of the smoking habits of patients was more
routinely performed in 2002 compared with the year
1997 both concerning all patients with respiratory symp-
toms and COPD patients.
The study site was chosen because of the availability of
electronic patient records, which were quite rare in
Finland at the beginning of the study. It is possible that
this particular health care center was more progressive
than most other primary health care centers concerning
implementing new guidelines. The role of specialized
health care for the improvement noticed could not be
assessed in this study, but it could have had a role in that.
An increase in the visits due to respiratory symptoms
from 1997 to 2002 was obvious and could have been partly
caused by increasing public knowledge concerning COPD
and respiratory diseases. Despite of that the number of
COPD patients visiting primary health care was on a
lower level than expected in both study years. In a recent
study the prevalence of COPD was 4.3% in men and 3.1%
in women in Finland [24]. Compared with this, numerous
undiagnosed patients with COPD probably existed in our
study population, or they did not visit primary health care.
Only one diagnosis code was routinely recorded on every
visit, and with this study method we were not able to find
those visits including COPD as other than primary cause
of visit. Some of the patients could have been followed in
specialized health care; we were not able to locate them in
our study. On the other hand, the Finnish diagnostic cri-
teria for COPD [19,22] were introduced before GOLD cri-
t e r i aw e r es e t ,a n dt h ec u t o f fp o i n tu s e df o rF E V 1 / F V C
was higher than in GOLD causing a possibility of over-
diagnosis of COPD.
A worrying figure was that only 8.0% of the patients had
been examined by spirometry in 1997. This is in concor-
dance with earlier studies [9,25], but far less than that
(52%) in a new study from Sweden [26]. PEF follow-up was
even less common. Without these two investigations, it
was not possible to judge whether patients had COPD or
asthma. After implementation of the national COPD pro-
gramme the use of spirometry improved significantly in
2002. Despite being crucial in the diagnostic process of
COPD, knowledge of deteriorated lung function affects the
success of smoking cessation attemps as a part of a motiva-
tional package [27,28]. Partly due to COPD programme as
well as for other reasons including a national asthma pro-
gramme launched before COPD programme the training
of primary health care professionals concerning COPD was
i m p r o v e da tt h es a m et i m e .T h e r ew e r es o m et e c h n i c a l
improvements in the recording of spirometry data in elec-
tronic patient records in the study period, which may have
partly improved the situation from 1997 to 2002.
The entire study group consisted of patients with
respiratory symptoms, but in 1997, only 16.6% had
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the biggest risk factor for COPD, and if ignored the
disease will often remain undiagnosed. This situation
improved greatly in 2002 when about half the patients
were correctly asked about smoking and the data were
recorded in patient records. During the study period,
more attention was paid to anti-smoking work and
corresponding legislation on the national level, which
could have had a role in the improvement noticed.
When patients admitted smoking, however the dura-
tion and heaviness of smoking was not always properly
recorded. The total amount of cigarettes smoked in
pack-years is important knowledge when estimating
the harmful effects of smoking as well as when aiming
to quit smoking [29].
Conclusion
A great increase in the use of spirometry and knowledge
of smoking habits of COPD patients was seen in this
specific health care center. A positive impact of the
national programme for detection of obstructive
pulmonary disease can partly explain this, but also other
improvements in the national level as well as in this par-
ticular healthcare center may have had a synergistic
effect on the approach. Whether this can be generalized
to other countries should be studied in the future, and
it would be optimal that future national programs will
include monitoring systems included in the programs.
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Table 1 Characteristics of the study patients, knowledge of their smoking habits, and use of spirometry in the study
groups, years 1997 and 2002
Group 1997 2002 p
N COPD 100 216 NA
1
Others 972 1429 NA
All 1072 1645 NA
Mean age (years ± SD) COPD 70.1 (11.3) 68.3 (13.0) 0.22
Others 51.7 (19.8) 53.4 (19.3) 0.03
All 53.4 55.4 0.96
Gender/male
N (%)
COPD 69 (69.0) 146 (67.6) 0.46
Others 342 (35.2) 463 (32.4) 0.09
All 411 (38.3) 609 (37.0) 0.49
PEF COPD 173.0 (260.3) 309.3 (148.4) 0.001
Others 263.3 (227.1) 414.8 (121.0) < 0.001
All 247.1 (235.0) 390.8 (135.0) < 0.001
FEV1/FVC COPD 61.9 (10.6) 67.4 (14.0) 0.04
Others 81.8 (6.4) 86.1 (18.1) 0.10
All 74.2 (12.7) 81.1 (19.0) 0.001
Data on smoking status available N (%) COPD 45 (45.0) 182 (84.3) < 0.001
Others 133 (13.7) 693 (48.5) < 0.001
All 178 (16.6) 875 (53.2) < 0.001
Pack years of smoking COPD 31.0 (9.8) 46.9 (17.9) 0.03
Others 25.9 (9.3) 24.5 (18.8) 0.86
All 27.2 (11.5) 37.3 (19.2) 0.03
Spirometry performed N (%) COPD 32 (32.0) 172 (79.6) < 0.001
Others 54 (5.6) 468 (32.8) < 0.001
All 86 (8.0) 640 (38.9) < 0.001
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